miRNAs deregulated between 2 sequential time points from patients with CLL with a progressive disease
| P‡ . | FDR . | Fold change† . | miRNA . |
|---|---|---|---|
| .0006 | .18 | 0.32 | miR-181b |
| .0015 | .21 | 0.56 | miR-130b |
| .0032 | .29 | 0.35 | miR-126* |
| .0066 | .46 | 0.54 | miR-296-3p |
| .0092 | .47 | 0.65 | miR-223 |
| .0125 | .47 | 0.61 | miR-130a |
| .0128 | .47 | 1.44 | miR-125a-3p |
| .0134 | .47 | 1.22 | miR-668 |
| .0152 | .47 | 0.64 | miR-299-3p |
| .0258 | .64 | 1.46 | miR-499-3p |
| .0274 | .64 | 1.21 | miR-412 |
| .0275 | .64 | 0.63 | miR-192 |
| .0357 | .72 | 1.24 | miR-193b |
| .0358 | .72 | 0.56 | miR-340 |
| .0427 | .80 | 1.36 | miR-93* |
| P‡ . | FDR . | Fold change† . | miRNA . |
|---|---|---|---|
| .0006 | .18 | 0.32 | miR-181b |
| .0015 | .21 | 0.56 | miR-130b |
| .0032 | .29 | 0.35 | miR-126* |
| .0066 | .46 | 0.54 | miR-296-3p |
| .0092 | .47 | 0.65 | miR-223 |
| .0125 | .47 | 0.61 | miR-130a |
| .0128 | .47 | 1.44 | miR-125a-3p |
| .0134 | .47 | 1.22 | miR-668 |
| .0152 | .47 | 0.64 | miR-299-3p |
| .0258 | .64 | 1.46 | miR-499-3p |
| .0274 | .64 | 1.21 | miR-412 |
| .0275 | .64 | 0.63 | miR-192 |
| .0357 | .72 | 1.24 | miR-193b |
| .0358 | .72 | 0.56 | miR-340 |
| .0427 | .80 | 1.36 | miR-93* |
FDR indicates false discovery rate.
Fold change is the fold ratio of the geometric means of miRNA expressions of paired samples with progressive disease. It is calculated with the use of the class comparison within the BRB Array tool.
Reported are the results of the class comparison analysis with the use of the approach last time point versus first time point. The analysis was performed by using Biometric Research Branch (BRB) Array tool Version 3.6.0.